Familial Cancer

, Volume 4, Issue 2, pp 127–133 | Cite as

A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history

  • Brindusa Truta
  • Brian A. Allen
  • Peggy G. Conrad
  • Vivian Weinberg
  • Glenn A. Miller
  • Rob Pomponio
  • Lara R. Lipton
  • Germano Guerra
  • Ian P. M. Tomlinson
  • Marvin H. Sleisenger
  • Young S. Kim
  • Jonathan P. Terdiman


Objectives: Adenomatous polyposis of the colon is often secondary to an inherited mutation in adenomatous polyposis coli (APC) gene, however, approximately one third of patients have no family history of the disease. We studied the phenotype and genotype of adenomatous polyposis in patients without a family history. Methods: A cohort of 57 unrelated adenomatous polyposis patients were evaluated. Seventeen patients with no family history were compared with 40 patients who had a positive family history of the disease. Family history and medical records were collected and analyzed. Germline APC and Mut Y homologue (MYH) testing was undertaken. Results: Patients without a family history were diagnosed with polyposis at an older age (41 years vs. 32 years) and presenting more frequently with symptoms (76 vs 20, P < 0.05). The number of colonic polyps and frequency of extracolonic manifestation associated with adenomatous polyposis did not differ between the two groups. APC mutations were detected less frequently among patients without a family history of the disease (4 out of 17 vs 25 out of 40, P=0.007), even among those with greater than 100 colorectal adenomas (4 out of 12 versus 21 out of 29, P=0.03). One homozygous MYH mutation carrier (G382D) was detected among the six patients without a family history and without a germline APC mutation who were tested. Conclusions: Adenomatous polyposis patients without a family history are usually diagnosed with symptoms, and at a later age. Phenotypically, they are similar to those with a family history. However, germline APC mutations are detected far less frequently in patients without a family history. A small percentage of these cases may be secondary to biallelic germline MYH mutations.


APC colon cancer familial adenomatous polyposis hereditary MYH polyps 



adenomatous polyposis coli


congenital hypertrophy of the retinal pigment epithelium


familial adenomatous polyposis


Mut Y homologue


protein truncation test


reverse transcriptase polymerase chain reaction


single strand conformation analysis


University California San Francisco


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Knudsen, LA, Bisgaard, ML, Bulow, S. 2003Attenuated familial adenomatous polyposis (AFAP)A review of the literature. Fam Cancer24355Google Scholar
  2. 2.
    Soravia, C, Berk, T, Madlensky, L,  et al. 1998Genotype-phenotype correlations in attenuated adenomatous polyposis coliAm J Hum Genet621290301CrossRefPubMedGoogle Scholar
  3. 3.
    Watson, AM, Zehnbauer, B, Kodner, I,  et al. 1995Genetic diagnosis of familial adenomatous polyposisLab Med Newslett316Google Scholar
  4. 4.
    Fearnhead, SN, Wilding, LJ, Bodmer, FW. 2002Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesisBr Med Bull642743CrossRefPubMedGoogle Scholar
  5. 5.
    Bisgaard, ML, Fenger, K, Bullow, S,  et al. 1994Familial adenomatous polyposis (FAP): frequency, penetrance and mutation rateHum Mutat31215PubMedGoogle Scholar
  6. 6.
    Bulow, S. 2003Result of national registration of familial adenomatous polyposisGut527426PubMedGoogle Scholar
  7. 7.
    Bertario, L, Russo, A, Sala, P,  et al. 2003Multiple approach to the exploration of genotype–phenotype correlations in familial adenomatous polyposisJ Clin Oncol211698707CrossRefPubMedGoogle Scholar
  8. 8.
    Beroud, C, Soussi, T. 1996APC gene: database of germline and somatic mutations in human tumors and cell linesNucleic Acid Res241214CrossRefPubMedGoogle Scholar
  9. 9.
    Lal, G, Gallinger, S. 2000Familial adenomatous polyposisSem Surg Oncol1831423CrossRefGoogle Scholar
  10. 10.
    Jarvinen, JH. 2003Genetic testing for polyposis: practical and ethical aspectsGut521922CrossRefGoogle Scholar
  11. 11.
    Heininiman, KMB, Weber, W, Attenhofer, M,  et al. 1998Phenotypic differences in familial adenomatous polyposis based on APC gene mutation statusGut4367579PubMedGoogle Scholar
  12. 12.
    Sieber, MO, Lipton, L, Crabtree, M,  et al. 2003Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYHN Engl J Med3437919CrossRefGoogle Scholar
  13. 13.
    Vande Luijt, R, Knan, PM, Vasen, H,  et al. 1994Rapid detection of translation-terminating mutations at the adenomatous poliposis coli (APC) gene by direct protein truncation testGenomics2014CrossRefPubMedGoogle Scholar
  14. 14.
    Orita, M, Suzuky, Y, Sekiya, T,  et al. 1989Rapid and sensitive detection of point mutation and DNA polymorphism using the polimerase chain reactionGenomics58749PubMedGoogle Scholar
  15. 15.
    Ponzde Leon, M, Benatti, P, Percesepe, A,  et al. 1999Clinical features and genotype–phenotype correlations in 41 Italian families with adenomatosis coliItal J Gastroenterol Hepatol3185060PubMedGoogle Scholar
  16. 16.
    Heininiman, K, Thompson, A, Locher, A,  et al. 2001Nontruncating APC germl-line mutations and mismach repair deficiency play a minor role in APC mutation-negative polyposisCancer Res61761622PubMedGoogle Scholar
  17. 17.
    Moisio, A-L, Jarvinen, H, Peltomaki, P. 2002Genetic and clinical characterisation of familial adenomatous polyposis: a population based studyGut5084550CrossRefPubMedGoogle Scholar
  18. 18.
    Rustin, RB, Jagelman, GD, McGannon, E,  et al. 1990Spontaneous mutation in familial adenomatous polyposisDis Colon Rectum33525PubMedGoogle Scholar
  19. 19.
    Giarola, M, Stagi, L, Presciuttini, S,  et al. 1999Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutationsHum Mutat1311623CrossRefPubMedGoogle Scholar
  20. 20.
    Friedl, W, Caspari, R, Sengteller, M,  et al. 2001Can APC mutation analysis contribute to the therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP familiesGut4851521CrossRefPubMedGoogle Scholar
  21. 21.
    Gavert, N, Yaron, Y, Naiman, T,  et al. 2002Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutationsHum Mutat1966470CrossRefPubMedGoogle Scholar
  22. 22.
    Giardello, F, Brensinger, JD, Peterson, G. 2001AGA technical review on hereditary colorectal cancer and genetic testingGastroenterology121198213PubMedGoogle Scholar
  23. 23.
    Laken, SJ, Papadopoulos, N,  et al. 1999Analysis of masked mutations in familial adenomatous polyposisProc Natl Acad Sci USA9623226CrossRefPubMedGoogle Scholar
  24. 24.
    LamlunH Tassan, AD, Jaeger, E,  et al. 2000Germline APC variants in patients with multiple adenomas, with evidence for the particular importance of E1317QHum Mol Genet9221521PubMedGoogle Scholar
  25. 25.
    Sampson, RJ, DolwaniS Jones, S,  et al. 2003Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYHLancet3623941PubMedGoogle Scholar
  26. 26.
    Wang, L, Baudhuin, ML, Boardman, AL.,  et al. 2004MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polypsGastroenterology127916CrossRefPubMedGoogle Scholar
  27. 27.
    Venesio, T, Molatore, S, Cattaneo, F,  et al. 2004High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposisGastroenterology12616815PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Brindusa Truta
    • 1
  • Brian A. Allen
    • 1
  • Peggy G. Conrad
    • 1
  • Vivian Weinberg
    • 1
  • Glenn A. Miller
    • 2
  • Rob Pomponio
    • 2
  • Lara R. Lipton
    • 3
  • Germano Guerra
    • 3
  • Ian P. M. Tomlinson
    • 3
  • Marvin H. Sleisenger
    • 4
  • Young S. Kim
    • 4
  • Jonathan P. Terdiman
    • 1
  1. 1.Department of Medicine, Division of Gastroenterology and the Comprehensive Cancer CenterUniversity of CaliforniaSan FranciscoUSA
  2. 2.Pharmacogenetics LaboratoryClinical Molecular Immunology Research Genzyme CorporationFraminghamUSA
  3. 3.Molecular and Population Genetics LaboratoryLondon Research InstituteUK
  4. 4.Department of Veteran Affairs Medical CenterSan FranciscoUSA

Personalised recommendations